Department of the Second General Surgery, Sheng Jing Hospital of China Medical University, No. 36, Sanhao Street, Heping District, Shenyang City, Liaoning Province, China.
World J Surg. 2019 Jun;43(6):1505-1518. doi: 10.1007/s00268-019-04946-8.
Laparoscopic partial splenectomy (LPS) is a challenging procedure. The aim of this review was to evaluate its feasibility, safety, and potential benefits.
We conducted a comprehensive review for the years 1995-2018 to retrieve all relevant articles.
A total of 44 studies with 252 patients undergoing LPS were reviewed. Six studies described combined operations. Ranges of operative time and estimated blood loss were 50-225 min and 0-1200 ml, respectively. There are eight patients need blood transfusion in 231 patients with available data. The conversion rate was 3.6% (9/252). Overall, 27 patients (10.7%;27/252) developed postoperative or intraoperative complications. Overall mortality was 0% (0/252). The length of postoperative stay (POS) varied (1-11 days). Among four comparative studies, one showed LPS could reduce POS than laparoscopic total splenectomy (LTS) (LTS 5.4 ± 1.8 days, LPS 4.2 ± 0.8 days, p = 0.027) and complications (pleural effusion (LTS 9/22, LPS 0/15, p = 0.005), splenic vein thrombosis (LTS 10/22, LPS 0/15, p = 0.002)). Another comparative study showed LPS may benefit emergency patients. However, one comparative study showed LPS was associated with more pain, longer time to oral intake, and longer POS in children with hereditary spherocytosis. The fourth comparative study showed robotic subtotal splenectomy was comparable to laparoscopy in terms of POS and complication. The main benefits were lower blood loss, vascular dissection time, and a better evaluation of splenic remnant volume.
In early series of highly selected patients, LPS appears to be feasible and safe when performed by experienced laparoscopic surgeons.
腹腔镜脾部分切除术(LPS)是一种具有挑战性的手术。本综述旨在评估其可行性、安全性和潜在益处。
我们对 1995 年至 2018 年的所有相关文章进行了全面综述。
共回顾了 44 项研究,其中 252 例患者接受了 LPS。有 6 项研究描述了联合手术。手术时间和估计失血量的范围分别为 50-225 分钟和 0-1200 毫升。在 231 例有可用数据的患者中,有 8 例需要输血。转化率为 3.6%(9/252)。总体而言,27 例(10.7%;27/252)患者术后或术中出现并发症。总体死亡率为 0%(0/252)。术后住院时间(POS)不同(1-11 天)。在四项比较研究中,有一项研究表明 LPS 可减少术后住院时间(LPS 4.2±0.8 天,LTS 5.4±1.8 天,p=0.027)和并发症(胸腔积液(LTS 9/22,LPS 0/15,p=0.005),脾静脉血栓形成(LTS 10/22,LPS 0/15,p=0.002))。另一项比较研究表明 LPS 可能对急诊患者有益。然而,另一项比较研究表明,对于遗传性球形红细胞增多症患儿,LPS 可能与更多疼痛、更长的口服摄入时间和更长的 POS 相关。第四项比较研究表明,机器人辅助部分脾切除术在 POS 和并发症方面与腹腔镜手术相当。主要优点是出血量低、血管分离时间短,并且可以更好地评估脾残体积。
在早期的高选择性患者系列中,经验丰富的腹腔镜外科医生进行 LPS 似乎是可行且安全的。